International Flavors & Fragrances Total Cost of Revenue increased by 1.4% to $1.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.7%, from $1.81B to $1.72B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -3.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.18B | $1.98B | $2.05B | $2.08B | $2.17B | $2.06B | $1.98B | $2.06B | $2.00B | $1.90B | $1.84B | $1.88B | $1.82B | $1.87B | $1.79B | $1.81B | $1.73B | $1.71B | $1.70B | $1.72B |
| QoQ Change | — | -9.1% | +3.5% | +1.5% | +4.3% | -5.0% | -4.2% | +4.5% | -3.2% | -5.0% | -2.8% | +1.7% | -2.9% | +2.9% | -4.4% | +0.9% | -4.1% | -1.3% | -0.7% | +1.4% |
| YoY Change | — | — | — | — | -0.4% | +4.1% | -3.7% | -0.9% | -8.1% | -8.1% | -6.7% | -9.1% | -8.8% | -1.2% | -2.8% | -3.6% | -4.8% | -8.6% | -5.1% | -4.7% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Food Ingredients | — | — | — | $609.00M | $642.00M | $642.00M | $638.00M | $646.00M |
| Scent | $328.00M | $353.00M | $330.00M | $344.00M | $336.00M | $374.00M | $370.00M | $375.00M |
| Taste | — | — | — | $377.00M | $377.00M | $379.00M | $367.00M | $375.00M |
| Health & Biosciences | — | — | — | $298.00M | — | — | $322.00M | — |
| Nourish | $1.04B | $1.04B | $1.04B | — | — | — | — | — |
| Pharma Solutions | $187.00M | $178.00M | $173.00M | $180.00M | $68.00M | — | — | — |
| Total | $1.82B | $1.87B | $1.79B | $1.81B | $1.73B | $1.71B | $1.70B | $1.72B |
Nourish is derived from annual filings.
Nourish, Pharma Solutions were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.